Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade

✍ Scribed by Manfred Böhm; Andrea Lippoldt; Wolfgang Wienen; Detlev Ganten; Michael Bader

• Book ID: 104761724
• Publisher: Springer
• Year: 1996
• Tongue: English
• Weight: 378 KB
• Volume: 163-164
• Category: Article
• ISSN: 0300-8177
• DOI: 10.1007/bf00408661

✦ Synopsis

TGR(mREN2)27 is a transgenic rat harboring the murine Ren-2 gene and exhibit fulminant hypertension and marked heart hypertrophy. In order to study the role of angiotensin II in the increase of cardiac mass, these animals were treated with antihypertensive and non-antihypertensive doses of the angiotensin II receptor AT 1 antagonist Telmisartan for 9 weeks. All doses led to significant reductions of heart hypertrophy detected by the evaluation of the diameter of cardiac muscle bundles. We conclude from this study that cardiac hypertrophy in TGR(mREN2)27 is characterized by an increased volume ofcardiomyocytes and an unchanged amount of fibrous tissue and that angiotensin II plays an important role in the mechanisms leading to this phenotype. (Mol Cell Biochem 163/164: 217-221, 1996)